Veterinary and Comparative Oncology Veterinary and Comparative Oncology RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Safety evaluation of combination carboplatin and toceranib phosphate (Palladia) in tumour ‐bearing dogs: A phase I dose finding study
The objective of this study was to establish the MTD, safety and adverse event (AE) profile of 1 such drug combination. This prospective phase I dose‐finding clinical trial assumed an open‐label 3 + 3 cohort design. Client‐owned dogs with 1 or more cytologically and/or histologically confirmed and macroscopically measurable, naive or recurrent, malignant tumours, were enrolled. No preference for tumour histology, grade or stage was expressed. Toceranib was administered at a dose of 2.75 mg kg−1 by mouth (PO) every other day (EOD), and carboplatin administered intravenously (IV) every 21 days at a starting dose of 2...
Source: Veterinary and Comparative Oncology - August 11, 2017 Category: Veterinary Research Authors: R. M. Wouda, S. E. Hocker, M. L. Higginbotham Tags: ORIGINAL ARTICLE Source Type: research

Safety evaluation of combination carboplatin and toceranib phosphate (Palladia) in tumour ‐bearing dogs: A phase I dose finding study
Veterinary and Comparative Oncology,Volume 16, Issue 1, Page E52-E60, March 2018. (Source: Veterinary and Comparative Oncology)
Source: Veterinary and Comparative Oncology - August 10, 2017 Category: Veterinary Research Source Type: research

---
Veterinary and Comparative Oncology,Volume 16, Issue 1, Page E52-E60, March 2018. (Source: Veterinary and Comparative Oncology)
Source: Veterinary and Comparative Oncology - August 10, 2017 Category: Veterinary Research Source Type: research

Cover Image, Volume 15, Issue 3
The cover image, by M. E. Gray et al., is based on the Original Article Dual targeting of EGFR and ERBB2 pathways produces a synergistic effect on cancer cell proliferation and migration in vitro, DOI: 10.1111/vco.12230. The cover image, by M. E. Gray et al., is based on the Original Article Dual targeting of EGFR and ERBB2 pathways produces a synergistic effect on cancer cell proliferation and migration in vitro, DOI: 10.1111/vco.12230. (Source: Veterinary and Comparative Oncology)
Source: Veterinary and Comparative Oncology - August 8, 2017 Category: Veterinary Research Authors: M. E. Gray, S. Lee, A. L. McDowell, M. Erskine, Q. T. M. Loh, O. Grice, D. J. Argyle, G. T. Bergkvist Tags: Cover Image Source Type: research

Temozolomide alone or in combination with doxorubicin as a rescue agent in 37 cases of canine multicentric lymphoma
Veterinary and Comparative Oncology, EarlyView. (Source: Veterinary and Comparative Oncology)
Source: Veterinary and Comparative Oncology - August 2, 2017 Category: Veterinary Research Source Type: research

---
Veterinary and Comparative Oncology, Ahead of Print. (Source: Veterinary and Comparative Oncology)
Source: Veterinary and Comparative Oncology - August 2, 2017 Category: Veterinary Research Source Type: research

Clinicopathologic features of lingual canine T ‐zone lymphoma
Veterinary and Comparative Oncology,Volume 16, Issue 1, Page 131-139, March 2018. (Source: Veterinary and Comparative Oncology)
Source: Veterinary and Comparative Oncology - July 27, 2017 Category: Veterinary Research Source Type: research

---
Veterinary and Comparative Oncology,Volume 16, Issue 1, Page 131-139, March 2018. (Source: Veterinary and Comparative Oncology)
Source: Veterinary and Comparative Oncology - July 27, 2017 Category: Veterinary Research Source Type: research

Linac ‐based stereotactic radiation therapy for canine non‐lymphomatous nasal tumours: 29 cases (2013‐2016)
Veterinary and Comparative Oncology,Volume 16, Issue 1, Page E68-E75, March 2018. (Source: Veterinary and Comparative Oncology)
Source: Veterinary and Comparative Oncology - July 25, 2017 Category: Veterinary Research Source Type: research

---
Veterinary and Comparative Oncology,Volume 16, Issue 1, Page E68-E75, March 2018. (Source: Veterinary and Comparative Oncology)
Source: Veterinary and Comparative Oncology - July 25, 2017 Category: Veterinary Research Source Type: research

Patient characteristics, prognostic factors and outcome of dogs with high ‐grade primary mediastinal lymphoma
Veterinary and Comparative Oncology,Volume 16, Issue 1, Page E45-E51, March 2018. (Source: Veterinary and Comparative Oncology)
Source: Veterinary and Comparative Oncology - June 28, 2017 Category: Veterinary Research Source Type: research

---
Veterinary and Comparative Oncology,Volume 16, Issue 1, Page E45-E51, March 2018. (Source: Veterinary and Comparative Oncology)
Source: Veterinary and Comparative Oncology - June 28, 2017 Category: Veterinary Research Source Type: research

Frameless stereotactic radiotherapy alone and combined with temozolomide for presumed canine gliomas
Veterinary and Comparative Oncology,Volume 16, Issue 1, Page 90-101, March 2018. (Source: Veterinary and Comparative Oncology)
Source: Veterinary and Comparative Oncology - June 23, 2017 Category: Veterinary Research Source Type: research

---
Veterinary and Comparative Oncology,Volume 16, Issue 1, Page 90-101, March 2018. (Source: Veterinary and Comparative Oncology)
Source: Veterinary and Comparative Oncology - June 23, 2017 Category: Veterinary Research Source Type: research

A dose ‐escalation study of combretastatin A4‐phosphate in healthy dogs
Veterinary and Comparative Oncology,Volume 16, Issue 1, Page E16-E22, March 2018. (Source: Veterinary and Comparative Oncology)
Source: Veterinary and Comparative Oncology - June 16, 2017 Category: Veterinary Research Source Type: research